High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Rapid Communications in Mass Spectrometry

• Publication date

  2011-10-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/rcm.5197PMID 21953957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Managing the challenge of chemically reactive metabolites in drug development

  2011cited by this paper
• Investigation of bioactivation of ticlopidine using linear ion trap/orbitrap mass spectrometry and an improved mass defect filtering technique.

  2010cited by this paper
• Analytical strategies for the screening and evaluation of chemically reactive drug metabolites.

  2009cited by this paper
• A liquid chromatography/tandem mass spectrometry method for detecting UGT-mediated bioactivation of drugs as their N-acetylcysteine adducts in human liver microsomes.

  2009cited by this paper
• Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry.

  2009cited by this paper
• Generic dealkylation: a tool for increasing the hit-rate of metabolite rationalization, and automatic customization of mass defect filters.

  2009cited by this paper
• Analytical strategies for the screening and evaluation of chemically reactive drug metabolites

  2009cited by this paper
• Quantitative-qualitative data acquisition using a benchtop orbitrap mass spectrometer

  2009cited by this paper
• Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry.

  2009cited by this paper
• Rapid detection and characterization of in vitro and urinary N-acetyl-L-cysteine conjugates using quadrupole-linear ion trap mass spectrometry and polarity switching.

  2009cited by this paper
• Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.

  2008cited by this paper
• A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.

  2008cited by this paper
• In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery.

  2008cited by this paper
• High-throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry.

  2008cited by this paper
• Dual negative precursor ion scan approach for rapid detection of glutathione conjugates using liquid chromatography/tandem mass spectrometry.

  2008cited by this paper
• Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography-high-resolution mass spectrometry and mass defect filtering.

  2007cited by this paper
• NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.

  2007cited by this paper
• When Should Clozapine Be Initiated in Schizophrenia?

  2007cited by this paper
• Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.

  2007cited by this paper
• Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry.

  2007cited by this paper
• MSE with mass defect filtering for in vitro and in vivo metabolite identification.

  2007cited by this paper
• Screening for reactive intermediates and toxicity assessment in drug discovery.

  2006cited by this paper
• Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry.

  2006cited by this paper
• Toxicophores: investigations in drug safety.

  2006cited by this paper
• Negative ion tandem mass spectrometry for the detection of glutathione conjugates.

  2005cited by this paper
• Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer.

  2005cited by this paper
• Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

  2005cited by this paper
• 'All-in-one' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching.

  2005cited by this paper
• A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition.

  2005cited by this paper
• BIOACTIVATION OF THE NONTRICYCLIC ANTIDEPRESSANT NEFAZODONE TO A REACTIVE QUINONE-IMINE SPECIES IN HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROME P450 3A4

  2005cited by this paper
• Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis.

  2005cited by this paper
• Combretastatin A4 phosphate: background and current clinical status

  2004cited by this paper
• Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.

  2004cited by this paper
• The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent.

  2004cited by this paper
• Reactive intermediates and the dynamics of glutathione transferases.

  2002cited by this paper
• Reactive metabolite screen for reducing candidate attrition in drug discovery.

  2001cited by this paper
• Disposition and metabolism of triprolidine in mice.

  1992cited by this paper

• Kendrick Mass Defect Analysis for Structural Characterization of Additives in Low-Viscosity Engine Oils: A Concise Review

  2025cites this paper
• Integration of non-targeted multicomponent profiling, targeted characteristic chromatograms and quantitative to accomplish systematic quality evaluation strategy of Huo-Xiang-Zheng-Qi oral liquid.

  2023cites this paper
• An integrated analytical strategy to decipher the metabolic profile of alkaloids in Compound Kushen injection based on UHPLC-ESI-QTOF/MSE

  2023cites this paper
• Liquid Chromatography‐Mass Spectrometry (LC‐MS) Quantification of Reactive Metabolites

  2021cites this paper
• Recent advances in mass spectrometric and other analytical techniques for the identification of drug metabolites

  2020cites this paper
• Simultaneously targeted and untargeted multicomponent characterization of Erzhi Pill by offline two-dimensional liquid chromatography/quadrupole-Orbitrap mass spectrometry.

  2019cites this paper
• Direct screening of malonylginsenosides from nine Ginseng extracts by an untargeted profiling strategy incorporating in-source collision-induced dissociation, mass tag, and neutral loss scan on a hybrid linear ion-trap/Orbitrap mass spectrometer coupled to ultra-high performance liquid chromatograph

  2018cites this paper
• Rapid screening and characterization of glutathione-trapped reactive metabolites using a polarity switch-based approach on a high-resolution quadrupole orbitrap mass spectrometer

  2018cites this paper
• Post-acquisition data mining techniques for LC-MS/MS-acquired data in drug metabolite identification.

  2017cites this paper
• Mass Defect from Nuclear Physics to Mass Spectral Analysis

  2017cites this paper
• Strategies for metabolite profiling based on liquid chromatography.

  2017cites this paper
• High-resolution mass spectrometry: basic principles for using exact mass and mass defect for discovery analysis of organic molecules in blood, breath, urine and environmental media

  2016cites this paper
• Tandem mass spectrometric analysis of S- and N-linked glutathione conjugates of pulegone and menthofuran and identification of P450 enzymes mediating their formation.

  2016cites this paper
• New metabolites of acteoside identified by ultra-performance liquid chromatography/quadrupole-time-of-flight MS(E) in rat plasma, urine, and feces.

  2016cites this paper
• Current mass spectrometry approaches and challenges for the bioanalysis of traditional Chinese medicines.

  2016cites this paper
• Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data.

  2015cites this paper
• AN IN VITRO INVESTIGATION INTO THE MECHANISM OF THE CLINICALLY RELEVANT DRUG-DRUG INTERACTION BETWEEN OMEPRAZOLE OR ESOMEPRAZOLE AND CLOPIDOGREL

  2015cites this paper
• Applications of mass spectrometry in drug metabolism: 50 years of progress*

  2015influential citation
• Screening of drugs of abuse and toxic compounds in human whole blood using online solid-phase extraction and high-performance liquid chromatography with time-of-flight mass spectrometry.

  2015cites this paper
• High-resolution MS: software, data processing and data management

  2014cites this paper
• Post-acquisition analysis of untargeted accurate mass quadrupole time-of-flight MS(E) data for multiple collision-induced neutral losses and fragment ions of glutathione conjugates.

  2014cites this paper
• Multivariate Analysis and Other Data Minding Technique to Visualize LC/MS Data

  2014cites this paper
• Applying ‘Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra’ (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry

  2014cites this paper
• Rapid identification of polyphenols in Kudiezi injection with a practical technique of mass defect filter based on high-performance liquid chromatography coupled with linear ion trap/orbitrap mass spectrometry

  2014cites this paper
• Coupling ultra-high-pressure liquid chromatography with mass spectrometry for in-vitro drug-metabolism studies

  2014cites this paper
• Characterization of Human Cytochrome P450s Involved in the Bioactivation of Clozapine

  2013cites this paper
• Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens.

  2013cites this paper
• High-throughput, computer assisted, specific MetID. A revolution for drug discovery.

  2013cites this paper
• Coupling ultra high-pressure liquid chromatography with mass spectrometry: constraints and possible applications.

  2013cites this paper
• Metabolite structure analysis by high-resolution MS: supporting drug-development studies.

  2013cites this paper
• Biotransformation pathways of biocides and pharmaceuticals in freshwater crustaceans based on structure elucidation of metabolites using high resolution mass spectrometry.

  2013cites this paper
• Exploring the utility of high-resolution MS with post-acquisition data mining for simultaneous exogenous and endogenous metabolite profiling.

  2013cites this paper
• Screening Reactive Metabolites: Role of Liquid Chromatography–High‐Resolution Mass Spectrometry in Combination with “Intelligent” Data Mining Tools

  2013cites this paper
• Resolving the microcosmos of complex samples: UPLC/travelling wave ion mobility separation high resolution mass spectrometry for the analysis of in vivo drug metabolism studies

  2013cites this paper
• Mass spectrometric tools for cell and tissue studies.

  2012cites this paper
• Integrated quantitative and qualitative workflow for in vivo bioanalytical support in drug discovery using hybrid Q-TOF-MS.

  2012cites this paper
• Mass spectrometry-based proteomics and peptidomics for systems biology and biomarker discovery

  2012cites this paper
• Enhanced detection and characterization of glutathione-trapped reactive metabolites by pseudo-MS(3) transition using a linear ion trap mass spectrometer.

  2012cites this paper
• The use of mass defect in modern mass spectrometry.

  2012cites this paper
• Simultaneous Screening of Glutathione and Cyanide Adducts Using Precursor Ion and Neutral Loss Scans-Dependent Product Ion Spectral Acquisition and Data Mining Tools

  2012influential citation
• Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control

  2012cites this paper
• High-Resolution Mass Spectrometry Elucidates Metabonate (False Metabolite) Formation from Alkylamine Drugs during In Vitro Metabolite Profiling

  2012cites this paper
• Hybrid Mass Analyzers in Drug Metabolism Applications

  2012cites this paper
• Application of LC-high-resolution MS with 'intelligent' data mining tools for screening reactive drug metabolites.

  2012cites this paper